About My Health Careers Internship MedBlogs Contact us

High Levels of an Enzyme Lowers Survival Rate in Leukemia Patients

by Hannah Joy on December 28, 2017 at 1:09 PM
Font : A-A+

High Levels of an Enzyme Lowers Survival Rate in Leukemia Patients

Acute myeloid leukemia patients were found to have higher levels of indoleamine 2,3 dioxygenase (IDO) enzyme that suppresses the immune system leading to early death in patients, reveals a new study.

High levels of this enzyme, indoleamine 2,3 dioxygenase, or IDO, at diagnosis also identify those who might benefit most by taking an IDO inhibitor along with their standard therapy, they report in the Nature journal Scientific Reports.


"We want to help people who are not responding to treatment and are dying very soon after their diagnosis," said Dr. Ravindra Kolhe, breast and molecular pathologist and director of the Georgia Esoteric & Molecular Labs LLC in the Department of Pathology at the Medical College of Georgia at Augusta University.

A review of 40 patients with acute myeloid leukemia, or AML, found increased IDO expression in the bone marrow biopsy, performed to diagnose their disease, correlated with lower overall survival rates and early mortality.

It also indicates that IDO expression should routinely be measured when the diagnostic bone marrow biopsy is performed, Kolhe says.

An early phase clinical study already is underway to begin to explore the IDO inhibitor's clinical potential in these patients. Sites include the Georgia Cancer Center at MCG as well as Johns Hopkins University and the University of Maryland Schools of Medicine, both in Baltimore.

NewLinks Genetics Corp., a biopharmaceutical company based in Ames, Iowa that produces the inhibitor Indoximod, is funding the study.

"We wanted to look at what makes this leukemia so aggressive that initial induction chemotherapy is not working," Kolhe says. "Early relapse tends to predict early mortality in these patients and one of the things we looked at was IDO," says the study's corresponding author.

While everyone has the IDO gene, it's the cancer cells in this scenario that activate the disabler of the immune response that is also used by the fetus and solid tumors, he says.

Stem cells in the bone marrow are supposed to mature into a variety of cells that enable our blood and immune system function. Instead in AML, stem cells get stuck in an in-between, undifferentiated state called blasts.

"It's very normal to go to the blast step, providing it matures from there," Kolhe says. "In leukemia, stem cells get limboed in the blast state so you don't get any maturation. That means there are low platelets so you get clotting problems, you have low neutrophils so you have infections, you have less red blood cells so you get anemic," he says.

In fact, bleeding is a major cause of death for patients and often, significant gum bleeding is the first indicator. The MCG researcher found one thing the blasts are producing is IDO.

"The patients who died at six months had a high expression of IDO while the blasts produced relatively little IDO in the patients who lived five years or more," Kolhe says.

"Most of the time, we don't know why patients are not responding to chemotherapy," he says. But when the researchers adjusted for other risk factors for AML, like increased age and severe anemia, IDO levels were a standout.

"Right now we know it's high in patients who die at six months and we show that it's an independent indicator if you adjust for other known variables," Kolhe says.

Next questions include whether high IDO directly affects resistance to chemotherapy, which occurs in patients who do not survive.

An MCG research team led by Dr. David Munn, pediatric hematologist/oncologist, and Dr. Andrew Mellor, immunologist, reported in 1998 in the journal Science that during pregnancy, cells in the placenta trigger an isolated suppression of the mother's immune system so it won't reject the genetically foreign fetus. They showed that IDO locally disables the mother's immune system by degrading tryptophan, an amino acid essential to survival of T cells, orchestrators of the immune system's response.

Later work would show that tumors - and leukemia - also use IDO to hide from the immune response. Conversely, some organ transplant patients who inexplicably express higher levels of IDO, have lower rejection rates of their new organ.

Kolhe, who completed his pathology residency at MCG and AU Health in 2012, got interested in IDO as at least one explanation for very different patient outcomes from the same treatments for the same disease.

Most patients with AML are at least age 45 at the time of diagnosis and it's slightly more common in men than women, according to the American Cancer Society. Induction therapy is given to get the patient into remission, and is typically followed by more chemotherapy to help ensure it stays dormant. Some patients may also receive a stem cell transplant.

Source: Eurekalert

News A-Z
News Category
What's New on Medindia
Black Pepper as Preventive Measure Against Omicron
FODMAP Diet: A Beginner's Guide
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Leukemia Chronic Myeloid Leukemia Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Multiple Myeloma Anal Warts Food Preservatives - How Safe Are They? Bone Marrow Transplantation Hairy Cell Leukemia 

Recommended Reading
Acute Myeloid Leukemia
Acute myeloid Leukemia, more popularly known by its abbreviated form AML, is a fast- evolving ......
Combination Therapy Shows Good Results For Acute Myeloid Leukemia
Venetoclax plus cobimetinib or idasanutlin may be synergistic and down-regulate a protein that ......
New Molecule Kills Resistant Cancer Cells in Acute Myeloid Leukemia
Scientists have discovered the first compound which kills resistant cancer cells in acute myeloid .....
Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is the cancer of white blood cells characterized by excess lympho...
Anal Warts
Anal warts or genital warts are soft bumps caused by Human Papilloma Virus and are a sexually transm...
Bone Marrow Transplantation
Preferred Term is Hematopoietic stem cell transplantation. In this stem cell from bone marrow are in...
Chronic Myeloid Leukemia
Chronic myeloid Leukemia is one of the most common types of blood cancer. It is characterized by ex...
Food Preservatives - How Safe Are They?
Food preservatives are basically antimicrobials or anti-oxidants that help preserve food by destroyi...
Hairy Cell Leukemia
Hairy cell leukemia (HCL) is a type of leukemia where there are increased numbers of abnormal B-lymp...
Encyclopedia section of medindia gives general information about Leukemia...
Multiple Myeloma
Multiple Myeloma caught public attention when model turned actress Lisa Ray, who worked in Deepa Meh...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use